Overview
- 53 inspections across 46 sites are on record.
- 175 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-09-20.
At a glance
Inspections
53
Sites
46
Observations
175
Career since
Dec 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Gregory Pharmaceutical Holdings, Inc., dba UPM Pharmaceuticals | 20 Sep 2024 | Human Drugs | View 483 → |
| Novartis Pharmaceuticals Corporation | 4 Sep 2014 | Human Drugs | |
| Allure Labs, LLC | 24 May 2013 | Human Drugs | View 483 → |
| BioZone Laboratories, Inc. | 29 Aug 2012 | View 483 → | |
| Apitoria Pharma Private Limited | 20 Jun 2012 |
Sites inspected
Gregory Pharmaceutical Holdings, Inc., dba UPM PharmaceuticalsBristol, United States1 insp.
Novartis Pharmaceuticals CorporationSan Carlos, United States1 insp.
Allure Labs, LLCHayward, United States1 insp.
BioZone Laboratories, Inc.Pittsburg, United States1 insp.
Apitoria Pharma Private LimitedSangareddy, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Peter E Baker11 shared
Karen D Phung6 shared
Mabel M Lee5 shared
Daniel J Roberts5 shared
Lance M De Souza4 shared
Jeanne A Young3 shared
Jennifer L Johnson2 shared
Henry K Lau2 shared
Jennifer H Rhyu2 shared
Quynh Strandberg2 shared
Full investigator report
Get the verbatim findings behind William V Millar's 175 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site